All 50 states sign up for Trump's Medicaid most-favored-nation plan

Steve Ubl, chief executive of industry lobby group PhRMA, criticized the new policies as "importing foreign prices from socialist countries."

"It would mean less treatments and cures and would jeopardize the hundreds of billions our member companies are planning to invest in America," Ubl said in a statement.

The White House has held several high-profile events with pharmaceutical executives this year to promote its efforts on healthcare costs, part of a broader push to highlight affordability before this year's midterm elections that will decide control of Congress.

Sept 18 (Reuters) - President Donald Trump plans to announce on Friday that all 50 states, the District of Columbia and Puerto Rico signed on to participate in his most-favored-nation drug pricing scheme for the Medicaid program for low-income Americans, a White House official said.